Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Othmane Jadi"'
Autor:
Stephanie M. Fogerson, Richard D. Mortensen, Regan P. Moore, Hellen Y. Chiou, Neel K. Prabhu, Angela H. Wei, Daniel Tsai, Othmane Jadi, Kwabena Andoh-Baidoo, Janice Crawford, Murotiwamambo Mudziviri, Daniel P. Kiehart
Publikováno v:
G3: Genes, Genomes, Genetics, Vol 10, Iss 11, Pp 4249-4269 (2020)
Externí odkaz:
https://doaj.org/article/a1e97ec34d364067ba45055442d80c47
Autor:
Waracharee Srifa, Nina Kosaric, Alvaro Amorin, Othmane Jadi, Yujin Park, Sruthi Mantri, Joab Camarena, Geoffrey C. Gurtner, Matthew Porteus
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Human mesenchymal stromal cells are a promising source for cell-based therapies. Here the authors use Cas9 to engineer lines that secrete PDGF-BB and VEFGA for improving wound healing.
Externí odkaz:
https://doaj.org/article/f1e0b2e3490d49f9b4d885258b1c4088
Autor:
Kelly S. Olsen, Othmane Jadi, Sarah Dexheimer, Dante S. Bortone, Steven P. Vensko, Sarah Bennett, Hancong Tang, Marisa Diiorio, Tanvi Saran, David Dingfelder, Qianqian Zhu, Yiwen Wang, Christopher A. Haiman, Loreall Pooler, Xin Sheng, Amy Webb, Marcelo C. Pasquini, Philip L. McCarthy, Stephen R. Spellman, Eric Weimer, Theresa Hahn, Lara Sucheston-Campbell, Paul M. Armistead, Benjamin G. Vincent
Publikováno v:
Blood Advances. 7:1635-1649
T-cell responses to minor histocompatibility antigens (mHAs) mediate graft-versus-leukemia (GVL) effects and graft-versus-host disease (GVHD) in allogeneic hematopoietic cell transplantation. Therapies that boost T-cell responses improve allogeneic h
Autor:
Othmane Jadi, Hancong Tang, Kelly Olsen, Steven Vensko, Qianqian Zhu, Yiwen Wang, Christopher A. Haiman, Loreall Pooler, Xin Sheng, Guy Brock, Amy Webb, Marcelo C. Pasquini, Philip L. McCarthy, Stephen R. Spellman, Theresa Hahn, Benjamin Vincent, Paul Armistead, Lara E. Sucheston‐Campbell
Publikováno v:
American Journal of Hematology. 98:940-950
Autor:
Kelly S Olsen, Othmane Jadi, Sarah Dexheimer, Dante Bortone, Steven Vensko, Sarah Bennett, Hancong Tang, Marisa Diiorio, Tanvi Saran, David Dingfelder, Qianqian Zhu, Yiwen Wang, Christopher A Haiman, Loreall Pooler, Xin Sheng, Amy Webb, Marcelo C Pasquini, Philip L McCarthy, Stephen R Spellman, Eric Weimer, Theresa Hahn, Lara Sucheston-Campbell, Paul Armistead, Benjamin Vincent
Publikováno v:
Blood. 140:4472-4474
T cell responses to minor histocompatibility antigens (mHAs) mediate graft versus leukemia (GvL) effects and graft versus host disease (GvHD) in allogeneic hematopoietic cell transplant (alloHCT). Therapies that boost T cell responses improve the eff
Autor:
Othmane Jadi, Hancong Tang, Kelly Olsen, Steven Vensko, Qianqian Zhu, Yiwen Wang, Christopher A Haiman, Loreall Pooler, Xin Sheng, Guy Brock, Amy Webb, Marcelo C. Pasquini, Philip L McCarthy, Stephen R. Spellman, Theresa Hahn, Benjamin Vincent, Paul Armistead, Lara E. Sucheston-Campbell
The role of minor histocompatibility antigens (mHAs) in mediating graft versus leukemia (GvL) and graft versus host disease (GvHD) following allogeneic hematopoietic cell transplantation (alloHCT) is recognized but not well-characterized. By implemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30df794fae1074beb5484cca9bf6d0ab
https://doi.org/10.1101/2022.08.31.506092
https://doi.org/10.1101/2022.08.31.506092
Autor:
Steven P. Vensko, Kelly Olsen, Dante Bortone, Christof C. Smith, Shengjie Chai, Wolfgang Beckabir, Misha Fini, Othmane Jadi, Alex Rubinsteyn, Benjamin G. Vincent
MotivationElimination of cancer cells by T cells is a critical mechanism of anti-tumor immunity and cancer immunotherapy response. T cells recognize cancer cells by engagement of T cell receptors with peptide epitopes presented by major histocompatib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42c96340cd54b69f916b98b484e2c3df
https://doi.org/10.1101/2022.04.01.486738
https://doi.org/10.1101/2022.04.01.486738
Autor:
Nina Kosaric, Waracharee Srifa, Matthew H. Porteus, Othmane Jadi, Sruthi Mantri, Alvaro Amorin, Joab Camarena, Geoffrey C. Gurtner, Yujin Park
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
Nature Communications
Nature Communications
Human mesenchymal stromal cells (hMSCs) are a promising source for engineered cell-based therapies in which genetic engineering could enhance therapeutic efficacy and install novel cellular functions. Here, we describe an optimized Cas9-AAV6-based ge
Autor:
Sarah Entwistle, Tao Wang, Kelly Olsen, Hancong Tang, Steven Vensko, Stephen R. Spellman, Junke Wang, Yiwen Wang, Xin Sheng, David Van Den Berg, Dante S. Bortone, Benjamin G. Vincent, Christopher A. Haiman, Theresa Hahn, Othmane Jadi, Loreall Pooler, Lara E. Sucheston-Campbell, Paul M. Armistead
Publikováno v:
Transplantation and Cellular Therapy. 27:S156-S158
Autor:
Eileen Smith, Jennifer R. Shingleton, Sandeep S. Dave, Jie Wang, Razvan Panea, Qiu Qin, Cassandra Love, Othmane Jadi, Nicholas S. Davis, Rachel Kositsky, Lanie Happ, Carolyn H. Baloh, Anupama Reddy, Naina Singhi, Devang Thakkar, Tushar Dave, Xiang Li
Publikováno v:
Cold Spring Harb Perspect Med
Non-Hodgkin lymphomas (NHLs) are a diverse group of entities, both clinically and molecularly. Here, we review the evolution of classification schemes in B-cell lymphoma, noting the now standard WHO classification system that is based on immune cell-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f3788f0f1a1ba7ed697a229096793c6
https://europepmc.org/articles/PMC7919396/
https://europepmc.org/articles/PMC7919396/